APA引用形式

Damiani, G., Conic, R. R., de Vita, V., Costanzo, A., Regazzini, R., Pigatto, P. D., . . . Malagoli, P. (2018). When IL-17 inhibitors fail: Real-life evidence to switch from secukinumab to adalimumab or ustekinumab. Dermatol Ther.

シカゴスタイル引用形

Damiani, Giovanni, Rosalynn RZ Conic, Valerio de Vita, Antonio Costanzo, Roberto Regazzini, Paolo DM Pigatto, Nicola L. Bragazzi, Alessia Pacifico, , Piergiorgio Malagoli. "When IL-17 Inhibitors Fail: Real-life Evidence to Switch From Secukinumab to Adalimumab or Ustekinumab." Dermatol Ther 2018.

MLA引用形式

Damiani, Giovanni, et al. "When IL-17 Inhibitors Fail: Real-life Evidence to Switch From Secukinumab to Adalimumab or Ustekinumab." Dermatol Ther 2018.